Hearing News and Research

RSS

Marshall Edwards receives non-compliance notice from NASDAQ

Marshall Edwards, Inc., an oncology company focused on the clinical development of novel anti-cancer therapeutics, announced today that it was notified on November 16, 2010 by the Listing Qualifications Staff of The NASDAQ Stock Market that, due to the Company's non-compliance with the minimum $10 million stockholders' equity requirement for continued listing on The NASDAQ Global Market, as set forth in Listing Rule 5450(b)(1), the Company's common stock is subject to delisting unless the Company requests a hearing before a NASDAQ Listing Qualifications Panel.

20 Nov 2010

State roundup: California PPOs 'low marks'; Geriatric nursing; Physician shortages

News outlets covered a range of developments including workforce issues in Minnesota and California, and a Kentucky order for insurers to provide child-only policies.

19 Nov 2010

Scientists discover bone matrix plays a vital role in tissue hardening

Scientists are reporting the first direct evidence that a subtle change in the physical properties of a tissue can affect its function. The finding has immediate implications for understanding several rare hearing disorders, they said, and ultimately could offer insight into such conditions as osteoporosis, arthritis, cardiovascular disease and cancer.

19 Nov 2010

Berwick's first hearing marked by strong defense of health law, GOP 'relative gentleness'

Centers for Medicare and Medicaid Services chief Dr. Donald Berwick survived his first Senate hearing yesterday by rebutting criticism of the health law and because Republicans were relatively gentle, The New York Times reports.

19 Nov 2010

Colo. nurse practitioners struggle for recognition, reimbursement; Mass. struggles with health care access

The Denver Post: "When nurse practitioner Mary Lou Hendrix opened her own high-risk-pregnancy practice in Evergreen and Cherry Creek last spring after more than 25 years of providing such care in physicians' offices, she was well-prepared for the medical challenges she would face. But she was not ready for the still-unresolved nightmare of trying to get recognized and reimbursed by insurance companies.

18 Nov 2010

US has highest out-of-pocket costs and most complex health insurance

A new 11-country survey from The Commonwealth Fund finds that adults in the United States are far more likely than those in 10 other industrialized nations to go without health care because of costs, have trouble paying medical bills, encounter high medical bills even when insured, and have disputes with their insurers or discover insurance wouldn't pay as they expected. According to the report, the findings highlight the need for Affordable Care Act reforms that will ensure access to health care, protect people from medical debt, and simplify health insurance.

18 Nov 2010

Lawmakers elbow for influence as they return to Capitol Hill

Lawmakers are elbowing around Capitol Hill to cement their places in the coming fight over health reform, and industry groups are attempting the same.

17 Nov 2010

Studies explore lifestyle's influence on wellness and brain health

New research is providing a deeper understanding of how individual actions - such as exercising, sensory stimulation, or drinking - influence brain health and outcomes. This new knowledge could ultimately lead to interventions in age-related cognitive declines, drug abuse, stroke, and brain injury, separate from or in combination with traditional pharmacological approaches. These findings were presented at Neuroscience 2010, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health.

17 Nov 2010

LFA encouraged by FDA Advisory Committee vote on BENLYSTA for autoimmune disease lupus

Today the U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee voted overwhelmingly (13 to 2) to recommend BENLYSTA® for approval as a treatment for the autoimmune disease lupus. If FDA approved, BENLYSTA would become the first new treatment for lupus in 52 years. While today's vote is a positive step, the FDA still must make a final decision to approve BENLYSTA in the coming weeks.

17 Nov 2010

New findings suggest brain sensory regions overlap to help people interpret environment

New research indicates that the integration of senses and functions in the brain is common. About two percent of the population has a condition called synesthesia, in which two different sensations, like color and sound, are experienced at once.

17 Nov 2010

Berwick to testify for the first time as Medicare/Medicaid chief

Medicare and Medicaid chief Donald Berwick will testify before a congressional committee Wednesday for the first time since President Barack Obama avoided the Senate confirmation process to Republican protest by using a recess appointment to install Berwick as the administrator of the Center for Medicare and Medicaid Services.

17 Nov 2010

Sonova 2010/11 first half sales increases 17.2% to CHF 832 million

Sonova generated a new sales record of CHF 832 million in the first half of 2010/11, an increase of 17.2% in Swiss francs compared to the previous year.

16 Nov 2010

OtoSCOPE method offers single-run genetic testing for hearing loss

Pinpointing the exact genetic cause of inherited deafness has always involved sequencing one gene at a time, a process that can take up to a year and cost roughly $1,000 per gene. It would cost around $75,000 to test all known deafness causing genes using this approach. Now University of Iowa researchers working with colleagues at Baylor College of Medicine have developed a test that can screen all of the genes known to cause deafness in a single run, in one to three months and for about $2,000.

16 Nov 2010

Science and precedent do not support biosimilar approach for plasma protein therapies

The current science and experience does not support the safety and efficaciousness of a biosimilar pathway for plasma protein therapies. At a public hearing last week, the Plasma Protein Therapeutics Association (PPTA) urged the United States Food and Drug Administration (FDA) to make patient safety its top priority by adopting a global approach in its evaluation of plasma protein therapies for the biosimilars process.

15 Nov 2010

NIMH intramural researcher to receive National Medal of Science

National Institutes of Health intramural researcher Mortimer Mishkin, Ph.D., will be awarded the National Medal of Science at a White House ceremony later this month. Mishkin is chief of the National Institute of Mental Health's (NIMH) Section on Cognitive Neuroscience, and acting chief of its Laboratory of Neuropsychology.

15 Nov 2010

Applied Precision installs 4 DeltaVision OMX super- resolution imaging systems in 8 weeks

Applied Precision, a leader in life science imaging solutions, is proud to announce the installation of four of its revolutionary DeltaVision OMX® super- resolution imaging system in a record timeframe of eight weeks.

12 Nov 2010

GOP prepares to grill Berwick at Senate hearing next week

Bloomberg: "Medicare Administrator Donald Berwick will face critics of President Barack Obama's health-care overhaul next week, his first appearance before Congress since he was appointed in a process that bypassed the Senate. Berwick will testify at a Senate Finance Committee hearing on Medicare, the health insurance program for the elderly and disabled, and the Medicaid program for the poor, the panel said today in a statement.

12 Nov 2010

Research on fruit flies reveal novel human pain gene

While it has become clear in recent years that susceptibility to pain has a strong inherited component, very little is known about actual "pain genes" and how they work. In the November 12th issue of Cell, researchers at Children's Hospital Boston and their collaborators report on a novel human pain gene. People with minor variations in this gene showed clear differences in susceptibility to acute heat pain and chronic back pain.

12 Nov 2010

First Edition: November 11, 2010

In today's headlines, health law advocates huddle in an effort to defend the measure against GOP efforts to undo it.

11 Nov 2010

New stem cell gene, enzyme replacement treatment for Tay-Sachs disease

StemCellRegenMed, Inc. announces that a new stem cell gene and enzyme replacement treatment has been performed on a fourteen month old child with Tay-Sachs disease on November 2, 2010. Tay-Sachs is a devastating disease that afflicts children primarily of parents of Jewish heritage and in very rare cases families of Eastern European background and the Cajun region in the U.S.A.

10 Nov 2010